An observational study in Fungemia, sponsored by Fundacion SEIMC-GESIDA. Completed at 29 sites in Spain. Per ClinicalTrials.gov, last updated 2013-04-23.
Sponsored by Fundacion SEIMC-GESIDA · Observational
The aim of this study is to describe the epidemiology of fungal blood infections in Spain (with emphasis on the incidence, fungal species distribution and antifungal susceptibility). The study is to be performed in five big cities which represent different geographic areas: Barcelona, Bilbao, Madrid, Sevilla and Valencia.
All patients with Candida sp or other fungal isolate obtained from a blood sample (fungemia episode)
Exclusion Criteria:
Patients with a fungal isolate from a blood culture
Other: Non intervention
Non interventional study
Describe fungemia epidemiology in Spain
Recollection of demographic variables (age, gender and ethnic origin); clinical variables (background diseases, other coinfections, treatment received, etc) and microbiological information of the isolate.
Time frame: 1 year
Describe differences among cities and institutions
Analyze results in function of the city and hospital where the isolate was obtained (5 cities in Spain and 29 participating hospitals)
Time frame: 1 year
Definition of risk factors
Determine risk factors for: * bad clinical evolution * infection by a specific Candida species * fluconazole resistant isolate * fungemia persistency
Time frame: 1 year
Determination of the fungal isolates susceptibility to fluconazole, voriconazole, caspofungine, anidulafungine, micafungine and anfotericine B
Analysis of resistant strains percentage according to the threshold established by CLSI to each specific antifungal
Time frame: 1 year
Correlation between fungemia with a diminished susceptibility fungal strain and clinical evolution
Chi-square and Kaplan-Meier survival curves
Time frame: 1 year
Correlation between reference and commercial microbiological methods
Comparison of results when a reference or a commercial fungal identification and antifungal susceptibility method is used.
Time frame: 1 year
This study is completed, as verified in Apr 2013. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Fundacion SEIMC-GESIDA